• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

AllianzGI Wellness Fund

+ Add to Watchlist

DGHCX:US

34.39 USD 0.41 1.21%

As of 09:29:30 ET on 10/20/2014.

Snapshot for AllianzGI Wellness Fund (DGHCX)

Year To Date: +14.98% 3-Month: +1.33% 3-Year: +24.13% 52-Week Range: 27.97 - 36.90
1-Month: -6.57% 1-Year: +22.95% 5-Year: +17.89% Beta vs MXWO0HC: 1.07

Mutual Fund Chart for DGHCX

No chart data available.
  • DGHCX:US 34.39
  • 1M
  • 1Y
Interactive DGHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DGHCX

AllianzGI Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invests at least 65% of its total assets in the equity securities of health care companies of anysize located in at least three different countries, which may include the United States.

Inception Date: 12-31-1996 Telephone: 1-888-852-3922
Managers: MICHAEL DAUCHOT / JOHN SCHROER
Web Site: www.allianzinvestors.com

Fundamentals for DGHCX

NAV (on 2014-10-20) 34.39
Assets (M) (on 2014-09-30) 174.77
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for DGHCX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-12) 1.93
Dividend Yield (ttm) 17.69

Fees & Expenses for DGHCX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.20
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.46

Top Fund Holdings for DGHCX

Filing Date: 08/31/2014
Name Position Value % of Total
Johnson & Johnson 81,555 8,459,700 4.902%
Gilead Sciences Inc 71,170 7,656,469 4.436%
Actavis plc 32,470 7,370,041 4.270%
Roche Holding AG 23,400 6,834,155 3.960%
Shire PLC 80,025 6,520,223 3.778%
HCA Holdings Inc 83,315 5,817,053 3.371%
Celgene Corp 57,270 5,441,795 3.153%
Puma Biotechnology Inc 20,520 5,345,665 3.097%
Salix Pharmaceuticals Ltd 32,400 5,155,164 2.987%
Boston Scientific Corp 387,950 4,919,206 2.850%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil